FibroGen
Price & Volume
Stats
See more52W Range | $0.18-$2.93 |
Market Cap | $46.6M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $173.8M |
Revenue Growth (YoY) | 14.3% |
Gross Profit (12 Mos) | -$59.7M |
Diluted EPS | -$1.20 |
News
See moreYahoo Finance • last year
FibroGen Reports Third Quarter 2023 Financial Results
Yahoo Finance • last year
FibroGen to Report Third Quarter 2023 Financial Results
Yahoo Finance • last year
FibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophy
Yahoo Finance • 2 years ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEN
About
CEO | Mr. Thane Wettig |
CFO | Mr. Juan Graham |
Address | 409 Illinois Street, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 486 |
